Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To get information about drug synthesis

— Chemical research, Spain

To identify pharmaceutical product patents and process patents, and drug patent expiries

— Global pharmaceutical regulatory affairs, India

For information on drug expiration / generic availability

— Pharmacist, USA

To find drug formulation information in patents

— Pharmaceutical developtment, Brazil

To obtain patent expiration information, so that the timeline for registration and launch of our generic products can be optimized.

— Business development manager, generics distribution company, Singapore

Generated: May 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075333

« Back to Dashboard
NDA 075333 describes CROMOLYN SODIUM, which is a drug marketed by Actavis Mid Atlantic, Bausch And Lomb, Akorn, Mylan Speciality Lp, Apotex Inc, Perrigo, Pharmascience Inc, Micro Labs Ltd India, Wockhardt, Genera Pharms, Watson Labs, Teva Pharms, Roxane, Hh And P, Alcon, and Pack Pharms Llc, and is included in nineteen NDAs. It is available from eleven suppliers. Additional details are available on the CROMOLYN SODIUM profile page.

The generic ingredient in CROMOLYN SODIUM is cromolyn sodium. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.

Summary for NDA: 075333

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Ophthalmic Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrength10MG/ML
Approval Date:Apr 30, 2002TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To identify pharmaceutical product patents and process patents, and drug patent expiries

— Global pharmaceutical regulatory affairs, India

To know the patent status of branded drugs to assist with reserve planning for large claims

— Medical director at managed care organiziation, USA

To review IP for certain products that are set to expire shortly

— Senior vice president, pharmaceutical wholesaler, Canada

To know which brands are on and off patent

— Advertising sales pharma companies, USA

To gain information on when to expect generics on the market in order to inform patients of when they can expect more affordable drugs

— Retail pharmacist, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot